Oshi Health, a New York-based virtual specialty care company, raised $30M in Series B funding.
The round was led by Koch Disruptive Technologies (KDT) with participation from existing investors Bessemer Venture Partners, Flare Capital Partners, Frist Cressey Ventures, CVS Health Ventures and Takeda Digital Ventures.
The company intends to use the funds to accelerate the next phase of its growth, to scale its clinical team nationwide and forge relationships with health plans, employers, channel partners, and provider groups to offer transformational multidisciplinary GI care.
Led by CEO Sam Holliday, Oshi Health:
- provides integrated diagnosis and treatment for digestive conditions and enables people to achieve lasting control of their symptoms,
- collaborates with employers, health insurance partners, health systems, and community GI practices to increase access to multidisciplinary care, reduce health care costs, and
- improve the lives of people with chronic gastrointestinal disease.
Oshi Health members work with a dedicated integrated team of GI specialists – board-certified gastroenterologists, registered dietitians, GI-specialized mental health clinicians, and nurse practitioners.
The company is currently available to over 20 million people as a preferred in-network virtual gastroenterology clinic for national and regional insurers, as well as their employer customers. The company also partners with community GI practices in a collaborative hybrid model to extend access to care, including reimbursed access to dietary and behavioral therapies proven to improve GI outcomes.
FinSMEs
11/04/2023